Evaluating RELiZORB Use for the Treatment of Feeding Intolerance in Adults With Moderate to Severe Acute Pancreatitis

Exclusion Criteria

• •Moribund patients expected to expire within 120 hours
• •Evidence of unresolved intestinal obstruction, ischemia, bleeding, perforation, fistulas or tract discontinuity, or other contraindication for enteral nutrition
• •Diagnosis or evidence of C. Difficile or other gastrointestinal infection that may manifest with diarrhea
• •Pre-existing constipation defined as laxative or stool softener use prior to admission to the hospital
• •Patients receiving cancer-related treatment in the last 3 months
• •History of cystic fibrosis
• •Any other reason that the treating or investigator team considers to be a contraindication to enteral nutrition